Childhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State. (OBEVIE)
Primary Purpose
Obesity
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Biological dosage
Sponsored by
About this trial
This is an interventional basic science trial for Obesity focused on measuring obesity, childhood trauma, hypothalamic-pituitary-adrenal axis, inflammation, metabolic syndrome
Eligibility Criteria
Inclusion Criteria:
- ≥18 years female BMI≥30kg/m2
Exclusion Criteria:
- History of bariatric surgery
Any condition or pathology that may influence the corticotropic axis or that may modify the excretion or dosage of cortisol:
- pregnancy, breastfeeding
- hepatocellular insufficiency,
- severe heart failure,
- mild/moderate acute heart failure,
- any psychological disorder not stabilised for at least one year
- alcohol or drug dependence, not weaned for at least one year
- neoplasm under treatment
- Current infectious disease or a history of autoimmune disease (except autoimmune hypothyroidism), inflammatory disease and/or neurodegenerative disease
- Presence of an adrenal adenoma or any known or suspected clinical adrenal or corticotropic disorder
- Subjects with a positive diagnosis of hypercorticism or suspected hypercorticism will also be excluded: 8-hour plasma cortisol after Dexamethasone suppression test (DST) (1 mg dexamethasone taken orally at midnight the previous day) greater than 1.8 microg/100 ml (50 nmol/l)
- antidepressant and neuroleptic treatment, benzodiazepine treatment
- treatment(s) likely to modify the exploration of the corticotropic axis: systemic or local corticosteroid therapy or glucocorticoid infiltration for less than 6 months
- current use of anti-inflammatory drugs or antibiotics
- Shift worker
Sites / Locations
- LimogesUniversity HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
All patients
Arm Description
Metabolic, hormonal and psychometric evaluations will be carried out during or after hospitalization inflammatory parameters, hormonal, capillary, saliva and urine assays will also be carried out
Outcomes
Primary Outcome Measures
Measurement of salivary cortisol awakening response (CAR)
Two salivary sampling at Day 0. The CAR is defined as the difference between the value of salivary cortisol collected 30 minutes after waking up and that on waking
Secondary Outcome Measures
Comparison of the amount of urinary free cortisol
Comparison of the amount of urinary free cortisol in obese women according to the presence of childhood trauma (assessed using CTQs)
Comparison of the amount of urinary free cortisol metabolites
Comparison of the amount of urinary free cortisol metabolites in obese women according to the presence of childhood trauma (assessed using CTQs)
Comparison of the amount of salivary cortisone
Comparison of the amount of salivary cortisone in obese women according to the presence of childhood trauma (assessed using CTQs)
Comparison of the amount of hair cortisol/cortisone
Comparison of the amount of hair cortisol/cortisone in obese women according to the presence of childhood trauma (assessed using CTQs)
comparison of the proportions of current anxiety/depression
comparison of the proportions of current anxiety/depression with Hospital Anxiety and Depression Scale according to the presence of childhood trauma (assessed using CTQs). This scale includes14 items rated from 0 to 3. Questions are separated in two categories, 7 for anxiety and 7 for depression. thus allowing 2 scores to be obtained with a maximum of 21 for each.
comparison of the proportions of current post-traumatic stress disorder (PTSD)
comparison of the proportions of current post-traumatic stress disorder with PCL-5 scale according to the presence of childhood trauma (assessed using CTQs)
comparison of the proportion of current eating disorders
comparison of the proportion of current eating disorders with Dutch Eating Behavior Questionnaire according to the presence of childhood trauma (assessed using CTQs)
Dosage of several parameters of inflammation (CRP, IL-1beta, IFN-alpha2, IFN-gamma, TNF-alpha, CCL2 (MCP-1), IL-6, CXCL8 (IL-8), IL-10, IL-12p70, IL-17A, IL-18, IL-23, l'IL-33, T lymphocytes and Myeloid-Derived Suppressor Cells immunophenotyping)
Comparison of the parameters of inflammation in obese women according to the presence of childhood trauma (assessed using CTQ)
comparison of body composition
comparison of body composition in obese women by biphotonic absorptiometry according to the presence of childhood trauma (assessed using CTQ)
Comparison of the choice of treatment modality
Comparison of the choice of treatment modality (medical or surgical) according to the presence of childhood trauma (assessed using CTQ)
Full Information
NCT ID
NCT05237440
First Posted
January 7, 2022
Last Updated
September 13, 2023
Sponsor
University Hospital, Limoges
1. Study Identification
Unique Protocol Identification Number
NCT05237440
Brief Title
Childhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State.
Acronym
OBEVIE
Official Title
Childhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 13, 2022 (Actual)
Primary Completion Date
May 13, 2024 (Anticipated)
Study Completion Date
May 13, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Limoges
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
We postulate that childhood traumas are associated with deregulation of the glucocorticoid axis and the inflammatory system in obese women. The main objective of the study is to compare the salivary cortisol awaking response in obese women according to the presence of childhood trauma (assessed using the Childhood Trauma Questionnaire, CTQ).
Detailed Description
Obesity is an epidemic disease whose onset and development factors go beyond the simple energy balance. Current management strategies are often failing. It is therefore important to identify the underlying determinants of weight gain. The association of obesity in adulthood with trauma in childhood is now well established. However, the biological factors that account for this association are imperfectly known. The measurement of cortisol seems to be the most relevant biological marker of the link between obesity and life events. The majority of studies show that obesity is associated with increased exposure to glucocorticoids. However, some authors have recently reported that these measures are impacted by significant inter-individual variability which could be explained by differences in life events and especially in their perception. In addition, the autonomic nervous system with the secretion of catecholamines by the adrenal leads to the release of pro-inflammatory cytokines, resulting in a low grade inflammation.
The existence of childhood traumas and the association with other psychopathological disorders will be assessed using psychometric scales validated in French. The corticotropic axis will be evaluated by measuring cortisol in different matrices (saliva, urine, hair). The inflammatory state will be studied thanks to the determination of pro-inflammatory cytokines level in blood and immunophenotyping of myeloid-derived suppressor cells.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obesity, childhood trauma, hypothalamic-pituitary-adrenal axis, inflammation, metabolic syndrome
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
102 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
All patients
Arm Type
Other
Arm Description
Metabolic, hormonal and psychometric evaluations will be carried out during or after hospitalization inflammatory parameters, hormonal, capillary, saliva and urine assays will also be carried out
Intervention Type
Biological
Intervention Name(s)
Biological dosage
Intervention Description
Metabolic, hormonal and psychometric evaluations will be carried out during inclusion inflammatory parameters, hormonal, capillary, saliva and urine assays will also be carried out at inclusion
Primary Outcome Measure Information:
Title
Measurement of salivary cortisol awakening response (CAR)
Description
Two salivary sampling at Day 0. The CAR is defined as the difference between the value of salivary cortisol collected 30 minutes after waking up and that on waking
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Comparison of the amount of urinary free cortisol
Description
Comparison of the amount of urinary free cortisol in obese women according to the presence of childhood trauma (assessed using CTQs)
Time Frame
Day 21
Title
Comparison of the amount of urinary free cortisol metabolites
Description
Comparison of the amount of urinary free cortisol metabolites in obese women according to the presence of childhood trauma (assessed using CTQs)
Time Frame
Day 21
Title
Comparison of the amount of salivary cortisone
Description
Comparison of the amount of salivary cortisone in obese women according to the presence of childhood trauma (assessed using CTQs)
Time Frame
Day 21
Title
Comparison of the amount of hair cortisol/cortisone
Description
Comparison of the amount of hair cortisol/cortisone in obese women according to the presence of childhood trauma (assessed using CTQs)
Time Frame
Day 21
Title
comparison of the proportions of current anxiety/depression
Description
comparison of the proportions of current anxiety/depression with Hospital Anxiety and Depression Scale according to the presence of childhood trauma (assessed using CTQs). This scale includes14 items rated from 0 to 3. Questions are separated in two categories, 7 for anxiety and 7 for depression. thus allowing 2 scores to be obtained with a maximum of 21 for each.
Time Frame
Day 0
Title
comparison of the proportions of current post-traumatic stress disorder (PTSD)
Description
comparison of the proportions of current post-traumatic stress disorder with PCL-5 scale according to the presence of childhood trauma (assessed using CTQs)
Time Frame
Day 0
Title
comparison of the proportion of current eating disorders
Description
comparison of the proportion of current eating disorders with Dutch Eating Behavior Questionnaire according to the presence of childhood trauma (assessed using CTQs)
Time Frame
Day 0
Title
Dosage of several parameters of inflammation (CRP, IL-1beta, IFN-alpha2, IFN-gamma, TNF-alpha, CCL2 (MCP-1), IL-6, CXCL8 (IL-8), IL-10, IL-12p70, IL-17A, IL-18, IL-23, l'IL-33, T lymphocytes and Myeloid-Derived Suppressor Cells immunophenotyping)
Description
Comparison of the parameters of inflammation in obese women according to the presence of childhood trauma (assessed using CTQ)
Time Frame
Day 21
Title
comparison of body composition
Description
comparison of body composition in obese women by biphotonic absorptiometry according to the presence of childhood trauma (assessed using CTQ)
Time Frame
Day -7
Title
Comparison of the choice of treatment modality
Description
Comparison of the choice of treatment modality (medical or surgical) according to the presence of childhood trauma (assessed using CTQ)
Time Frame
Day 21
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
≥18 years female BMI≥30kg/m2
Exclusion Criteria:
History of bariatric surgery
Any condition or pathology that may influence the corticotropic axis or that may modify the excretion or dosage of cortisol:
pregnancy, breastfeeding
hepatocellular insufficiency,
severe heart failure,
mild/moderate acute heart failure,
any psychological disorder not stabilised for at least one year
alcohol or drug dependence, not weaned for at least one year
neoplasm under treatment
Current infectious disease or a history of autoimmune disease (except autoimmune hypothyroidism), inflammatory disease and/or neurodegenerative disease
Presence of an adrenal adenoma or any known or suspected clinical adrenal or corticotropic disorder
Subjects with a positive diagnosis of hypercorticism or suspected hypercorticism will also be excluded: 8-hour plasma cortisol after Dexamethasone suppression test (DST) (1 mg dexamethasone taken orally at midnight the previous day) greater than 1.8 microg/100 ml (50 nmol/l)
antidepressant and neuroleptic treatment, benzodiazepine treatment
treatment(s) likely to modify the exploration of the corticotropic axis: systemic or local corticosteroid therapy or glucocorticoid infiltration for less than 6 months
current use of anti-inflammatory drugs or antibiotics
Shift worker
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laurence SALLE, MD
Phone
555049818
Ext
+33
Email
laurence.salle@chu-limoges.fr
Facility Information:
Facility Name
LimogesUniversity Hospital
City
Limoges
ZIP/Postal Code
87049
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laurence SALLE, MD
Email
laurence.salle@chu-limoges.fr
First Name & Middle Initial & Last Name & Degree
Laurence SALLE, MD
12. IPD Sharing Statement
Learn more about this trial
Childhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State.
We'll reach out to this number within 24 hrs